Cytoprotection in acute myocardial infarction

International Journal of Cardiology

Volumn 72, Issue 1, 1999, Pages 1-2

  Doehner, W ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; INSULIN; POTASSIUM; TRIMETAZIDINE;

ACUTE HEART INFARCTION; CELL PROTECTION; EDITORIAL; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; OXYGEN SUPPLY; PRIORITY JOURNAL;

EID: 84928159384     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/S0167-5273(99)00154-0     Document Type: Review

References (6)

1. H.E. Castagnino Great expectations from a different approach to the treatment of acute myocardial infarction cytoprotection Int J Cardiol. 69 1999 15 18
2. E. Boddeke, J. Hugtenburg, W. Jap, J. Heynis, and P. van Zwieten New anti-ischaemic drugs: cytoprotective action with no primary haemodynamic effects Trends Pharmacol Sci. 10 1989 397 400
3. D. Sodi-Pallares, M. Testelli, and F. Fishleder Effects of an intravenous infusion of a potassium-insulin-glucose solution on the electrocardiographic signs of myocardial infarction Am J Cardiol. 9 1962 166 181
4. C.S. Apstein Metabolic approaches in ischaemic heart disease Eur Heart J Supplements. 1 1999 O32 O39
5. W.C. Stanley, G.D. Lopaschuk, J.L. Hall, and J.G. McCormack Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions Potential for pharmacological interventions.Cardiovasc Res. 33 1997 243 257
6. J.M. Detry Clinical features of an anti-anginal drug in angina pectoris Eur Heart J. 14 1993 18 24 Suppl G